About Us
Transpharmative Advisors brings lasting value to pharmaceutical products by designing efficient, well-protected and commercially valuable pathways to market.
The Transpharmative team has years of experience in creatively developing, protecting and marketing pharmaceutical products that have generated more than $1 billion in revenue. Specifically, the team has
The Transpharmative team has years of experience in creatively developing, protecting and marketing pharmaceutical products that have generated more than $1 billion in revenue. Specifically, the team has
- Designed unique 505(b)(2) regulatory strategies that resulted in prompt, efficient and seamless FDA approval
- Created multiple Orange Book listed patents for new NDAs of previously approved molecules
- Successfully petitioned FDA to require that all comparable products be required to include appropriate safety and/or efficacy information and certify to all relevant patents protecting the product
- Identified pathways that avoid unnecessary and expensive Waxman-Hatch litigation by bringing comparable 505(b)(2) products to market